<!-- headlesslaw {"release":{"id":"a4f2a0495fe55b47323883f82977a9b34ab66171ec9623e39925d3a7045b6c81","published":"2026-11-01T16:41:30Z","pinned":false},"limits":{"coverage":{"history":"current_only","held_since":"2019-12-04","gaps":[],"covered":["ESMA Q&A 1127 — Q&A — Product intervention [Answer Published] L3"],"not_covered":["national guidance","court decisions"]},"freshness":{"release_id":"a4f2a0495fe55b47323883f82977a9b34ab66171ec9623e39925d3a7045b6c81","release_published":"2026-11-01T16:41:30Z","checked_at":"2026-10-26","checked_against":"the ESMA publication"},"truncation":null,"failures":[],"incomplete":[]},"page":{"path":"/mifir/level-3/q-and-a/esma/esma-qa-1127-product-intervention","url":"https://www.headlesslaw.com/mifir/level-3/q-and-a/esma/esma-qa-1127-product-intervention","title":"ESMA Q&A 1127 — Q&A — Product intervention [Answer Published]","family":"l3","work_id":"spaces/mifir/level-3/q-and-a/esma/esma-qa-1127-product-intervention","status":"answer published","force_status":null,"date_state":"current","requested_date":null,"as_of":"2026-11-01","applies_from":null,"application":null,"version_label":"ESMA Q&A register, 4 December 2019","check":{"against":"the ESMA publication","on":"2026-10-26"},"check_result":"matched","official_url":"https://www.esma.europa.eu/publications-data/questions-answers/1127","valid_from":"0001-01-01","valid_until":null,"revision":1,"content_id":"f16baadc9521292b","change_date":null,"nearest_versions":["2019-12-04"],"first_text_date":null,"correction_applies":false,"versions":["2019-12-04"],"version_url":"https://www.headlesslaw.com/mifir/level-3/q-and-a/esma/esma-qa-1127-product-intervention/versions/2019-12-04","revision_url":"https://www.headlesslaw.com/mifir/level-3/q-and-a/esma/esma-qa-1127-product-intervention/versions/2019-12-04/rev/f16baadc9521292b","versions_url":"https://www.headlesslaw.com/mifir/level-3/q-and-a/esma/esma-qa-1127-product-intervention/versions","relations_url":"https://www.headlesslaw.com/mifir/level-3/q-and-a/esma/esma-qa-1127-product-intervention/relations","source_line":"Answer by ESMA, published in its Q&A tool · not legislation · published 4 Dec 2019 [Answer Published]","attribution":{"prepared_by":"ESMA","published_by":"ESMA","published_in":"ESMA Q&A tool","document_type":"qa_answer","legal_nature":"not_legislation","addressees":"not stated in the document","dates":{"published_on":"2019-12-04","question_submitted_on":"2019-12-04","locators":{"published_on":"ESMA Q&A Excel export ESMA_QA_1127, column 'Esma responses', date line","question_submitted_on":"ESMA Q&A Excel export ESMA_QA_1127, column 'Date of submission'"}},"adoption":null}}} -->
---
title: "ESMA Q&A 1127 — Q&A — Product intervention [Answer Published]"
shortTitle: "ESMA Q&A 1127 — Q&A — Product intervention [Answer Published]"
answer_id: ESMA_QA_1127
topic: "Product governance"
status: "Answer Published"
type: qa
instrument_type: qa
authority: ESMA
binding: false
binding_character: non_binding
legal_status: in_force
regulation: "MiFIR"
mifir_level3: true
mica_level2: false
legal_basis: "MiFIR"
date: 4 December 2019
source_link: https://www.esma.europa.eu/publications-data/questions-answers/1127
lifecycle: "Answer Published"
text_version: "ESMA Q&A register, 4 December 2019"
source_url: "https://www.esma.europa.eu/publications-data/questions-answers/1127"
check_status: matched
verified: true
last_checked: 2026-10-26
checked_against: "the ESMA publication"
source:
  prepared_by: "ESMA"
  published_by: "ESMA"
  published_in: "ESMA Q&A tool"
  evidence:
    prepared_by: "ESMA Answer"
    locator: "ESMA Q&A entry ESMA_QA_1127: field 'ESMA Answer', no 'Answer provided by' line"
document_type: "qa_answer"
legal_nature: "not_legislation"
addressees: "not stated in the document"
dates:
  published_on: "2019-12-04"
  question_submitted_on: "2019-12-04"
  locators:
    published_on: "ESMA Q&A Excel export ESMA_QA_1127, column 'Esma responses', date line"
    question_submitted_on: "ESMA Q&A Excel export ESMA_QA_1127, column 'Date of submission'"
lifecycle_label: "Answer Published"
---

**Answer by ESMA, published in its Q&A tool · not legislation · published 4 Dec 2019 [Answer Published]**

*Answer Published · ESMA Q&A register, 4 December 2019 · Checked against the ESMA publication on 26 Oct 2026 · [Official source](https://www.esma.europa.eu/publications-data/questions-answers/1127)*

| | |
|---|---|
| **Full title** | ESMA Q&A 1127 — Q&A — Product intervention \[Answer Published\] |
| **Prepared by** | ESMA |
| **Published by** | ESMA, in the ESMA Q&A tool |
| **Reference** | ESMA_QA_1127 |
| **Document type** | Q&A |
| **Legal nature** | Not legislation |
| **Addressees** | Not stated in the document |
| **Dates** | Published 4 December 2019; question submitted 4 December 2019 |
| **Legal basis** | MiFIR |
| **Related instruments** | None recorded |
| **Text on this page** | Word for word — the full text of the ESMA publication |

**Product intervention**

### Question

Which national product intervention measures should a firm apply in case of cross-border provision of investment services?

***

### Answer

\[ESMA35-43-439 Investor protection Product intervention Q&A 1\]

National competent authorities (NCAs) may take product intervention measures in accordance with Article 42 of the Markets in Financial Instruments Regulation (EU) No 600/2014 (MiFIR) in or from their Member State. Where two NCAs adopt product intervention measures that both apply in and from their Member State and that are different from each other, it is important for investment firms to comply with the product intervention measures that apply from the Member State in which they are authorised in case of cross-border provision of investment services and also the product intervention measures applicable in a Member State where the client is located.

This holds that if Member State (MS) A adopts stricter measures than MS B, then firms from MS B still have to abide by the national product intervention measures of MS A in respect of any cross-border activity provided to clients in MS A that is within the scope of the national measures of MS A.

When product intervention measures in a Member State apply from that Member State, this implies that the product intervention measures apply to firms when marketing, distributing or selling MiFID financial instruments also to clients located in third country jurisdictions, without prejudice of any local legislation and/or regulation.

In order to determine the location of the client, firms could, for example, consider the habitual residence of the client based on information collected in their client-onboarding process as part of the know-your-customer assessment.

It is possible that national product intervention measures contain specific rules on the territorial scope of their application. Therefore, when providing cross-border investment services firms should ensure compliance with the applicable product intervention measures.

***

**Source:** [ESMA original document](https://www.esma.europa.eu/publications-data/questions-answers/1127)